Achieving Cell-Specific Delivery of Multiple Oligonucleotide Therapeutics with Aptamer Chimeras
<p>Current standard cancer treatments such as chemotherapeutics, and radiation therapy are nearly as likely to kill the patient as cure the cancer. Therapies that have such a narrow window of efficacy are necessary for the treatment of aggressive diseases, but safer alternatives must be create...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
2012
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10161/6108 |